Literature DB >> 33161482

Narrative Review: Headaches After Reversible Cerebral Vasoconstriction Syndrome.

Yu-Hsiang Ling1,2, Shih-Pin Chen3,4,5,6,7.   

Abstract

PURPOSE OF REVIEW: Reversible cerebral vasoconstriction syndrome (RCVS) is a disorder with distinct features: recurrent thunderclap headaches with reversible vasoconstriction of intracranial arteries. Substantial studies regarding outcomes after RCVS were conducted, showing favorable functional outcomes in most patients despite the potentially life-threatening complications of RCVS, including ischemic stroke, intracranial hemorrhage, or convexity subarachnoid hemorrhage. However, patients may report headaches after the resolution of RCVS while relative studies were scarce. RECENT
FINDINGS: Two prospective studies from different cohorts consistently revealed that RCVS recurred in at least 5% of patients. Patients with prior migraine history and patients whose thunderclap headaches are elicited by sexual activity or exertion are at higher risk for RCVS recurrence. On the other hand, several retrospective studies and case reports reported that chronic headaches are common in RCVS patients after the resolution of acute bouts. The chronic headaches after RCVS are sometimes disabling in certain patients. Headaches after RCVS are not uncommon but usually overseen. Medical attention and examinations are warranted in patient with RCVS who reported recurrence of thunderclap headaches or chronic headaches after RCVS.

Entities:  

Keywords:  Chronic headache; Persistent headache; Recurrence; Reversible cerebral vasoconstriction syndrome; Thunderclap headache

Year:  2020        PMID: 33161482     DOI: 10.1007/s11916-020-00908-1

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  1 in total

1.  CT angiography and diffusion-perfusion MR imaging in a patient with ipsilateral reversible cerebral vasoconstriction after carotid endarterectomy.

Authors:  M H Rosenbloom; A B Singhal
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

  1 in total
  1 in total

Review 1.  Pathophysiology of reversible cerebral vasoconstriction syndrome.

Authors:  Shih-Pin Chen; Shuu-Jiun Wang
Journal:  J Biomed Sci       Date:  2022-09-21       Impact factor: 12.771

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.